Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is The Hydration Pharmaceuticals Co Cash Ratio?
The Hydration Pharmaceuticals CoASX:HPC Cash Ratio is 1.45 as of Dec. 2025, which is at its 10-year median of 1.45. The stock has 3 warning signs investors should review. Among 304 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks better than 86.18% on this metric.
The Hydration Pharmaceuticals Co has a Cash Ratio of 1.45. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for The Hydration Pharmaceuticals Co's Cash Ratio or its related term are showing as below:
ASX:HPC'
s Cash Ratio Range Over the Past 10 Years
Min: 0.59 Med: 1.45 Max: 5.25
Current: 1.45
During the past 5 years, The Hydration Pharmaceuticals Co's highest Cash Ratio was 5.25. The lowest was 0.59. And the median was 1.45.
ASX:HPC's Cash Ratio is ranked better than 86.18% of 304
companies
in the Retail - Defensive industry
Industry Median: 0.29
vs ASX:HPC: 1.45
The Hydration Pharmaceuticals Co (ASX:HPC) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
The Hydration Pharmaceuticals Co Cash Ratio Related Terms
The Hydration Pharmaceuticals Co Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co Cash Ratio vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's Cash Ratio distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co (ASX:HPC) has a Cash Ratio of 1.45 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on The Hydration Pharmaceuticals Co and its competitors. This is near median its historical median of 1.45. Over the past decade, The Hydration Pharmaceuticals Co's Cash Ratio has ranged from 0.59 to 5.25. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #42 out of 304 companies in the Retail - Defensive industry, placing it in the top 13.8%.
Is The Hydration Pharmaceuticals Co's Cash Ratio too high?
The Hydration Pharmaceuticals Co's current Cash Ratio of 1.45 is near median its 10-year median of 1.45. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 5.25. The Retail - Defensive industry median Cash Ratio is 0.29. The Hydration Pharmaceuticals Co's value of 1.45 is 400% above this industry median. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #42 out of 304 companies in the Retail - Defensive industry, which is in the top quartile — a strong position relative to peers.
How does The Hydration Pharmaceuticals Co's Cash Ratio compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #42 out of 304 companies for Cash Ratio. This places The Hydration Pharmaceuticals Co in the top 14% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.29. The Hydration Pharmaceuticals Co's value of 1.45 is 400% above this benchmark. Historically, The Hydration Pharmaceuticals Co's own Cash Ratio has ranged from 0.59 to 5.25 over the past decade. While the company's 10-year median is 1.45 vs. the industry median of 0.29, The Hydration Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Retail - Defensive company?
The median Cash Ratio among Retail - Defensive companies is 0.29, based on 304 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Hydration Pharmaceuticals Co's current Cash Ratio of 1.45 is 400% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median Cash Ratio is 0.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current Cash Ratio is 1.45, which is near median its own 10-year median of 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Cash Ratio of 1.45. The current Cash Ratio is 1.45, which is near median its 10-year median of 1.45 and 400% above the Retail - Defensive industry median of 0.29. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Cash Ratio is 1.45 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 
